Sec. 7161. Preventing overdoses of controlled substances
1,219 words·~6 min read·
/bill/115/hr/6/eah/section-7161A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part J of title III of the Public Health Service Act ( 42 U.S.C. 280b et seq.) is amended by inserting after section 392 ( 42 U.S.C. 280b–1 ) the following: The Director of the Centers for Disease Control and Prevention may— to the extent practicable, carry out and expand any evidence-based prevention activities described in paragraph (2); provide training and technical assistance to States, localities, and Indian tribes for purposes of carrying out such activity; and award grants to States, localities, and Indian tribes for purposes of carrying out such activity.
An evidence-based prevention activity described in this paragraph is any of the following activities: Improving the efficiency and use of a new or currently operating prescription drug monitoring program, including by— encouraging all authorized users (as specified by the State or other entity) to register with and use the program; enabling such users to access any updates to information collected by the program in as close to real-time as possible; improving the ease of use of such program; providing for a mechanism for the program to notify authorized users of any potential misuse or abuse of controlled substances and any detection of inappropriate prescribing or dispensing practices relating to such substances; encouraging the analysis of prescription drug monitoring data for purposes of providing de-identified, aggregate reports based on such analysis to State public health agencies, State substance abuse agencies, State licensing boards, and other appropriate State agencies, as permitted under applicable Federal and State law and the policies of the prescription drug monitoring program and not containing any protected health information, to prevent inappropriate prescribing, drug diversion, or abuse and misuse of controlled substances, and to facilitate better coordination among agencies; enhancing interoperability between the program and any health information technology (including certified health information technology), including by integrating program data into such technology; updating program capabilities to respond to technological innovation for purposes of appropriately addressing the occurrence and evolution of controlled substance overdoses; facilitating and encouraging data exchange between the program and the prescription drug monitoring programs of other States; enhancing data collection and quality, including improving patient matching and proactively monitoring data quality; providing prescriber and dispenser practice tools, including prescriber practice insight reports for practitioners to review their prescribing patterns in comparison to such patterns of other practitioners in the specialty; and meeting the purpose of the program established under section 399O, as described in section 399O(a).
Promoting community or health system interventions. Evaluating interventions to prevent controlled substance overdoses. Implementing projects to advance an innovative prevention approach with respect to new and emerging public health crises and opportunities to address such crises, such as enhancing public education and awareness on the risks associated with opioids. The Director may award grants to States, localities, and Indian Tribes— to carry out innovative projects for grantees to rapidly respond to controlled substance misuse, abuse, and overdoses, including changes in patterns of controlled substance use; and for any other evidence-based activity for preventing controlled substance misuse, abuse, and overdoses as the Director determines appropriate.
The Director, in coordination with the Assistant Secretary for Mental Health and Substance Use and the National Mental Health and Substance Use Policy Laboratory established under section 501A, as appropriate and applicable, may conduct studies and evaluations to address substance use disorders, including preventing substance use disorders or other related topics the Director determines appropriate. The Director of the Centers for Disease Control and Prevention may— to the extent practicable, carry out any controlled substance overdose data collection activities described in paragraph (2); provide training and technical assistance to States, localities, and Indian tribes for purposes of carrying out such activity; award grants to States, localities, and Indian tribes for purposes of carrying out such activity; and coordinate with the Assistant Secretary for Mental Health and Substance Use to collect data pursuant to section 505(d)(1)(A) (relating to the number of individuals admitted to emergency departments as a result of the abuse of alcohol or other drugs).
A controlled substance overdose data collection, analysis, and dissemination activity described in this paragraph is any of the following activities: Improving the timeliness of reporting data to the public, including data on fatal and nonfatal overdoses of controlled substances. Enhancing the comprehensiveness of controlled substance overdose data by collecting information on such overdoses from appropriate sources such as toxicology reports, autopsy reports, death scene investigations, and emergency departments.
Modernizing the system for coding causes of death related to controlled substance overdoses to use an electronic-based system. Using data to help identify risk factors associated with controlled substance overdoses. Supporting entities involved in providing information on controlled substance overdoses, such as coroners, medical examiners, and public health laboratories to improve accurate testing and standardized reporting of causes and contributing factors to controlled substances overdoses and analysis of various opioid analogues to controlled substance overdoses.
Working to enable and encourage the access, exchange, and use of information regarding controlled substance overdoses among data sources and entities. In this section: The term controlled substance has the meaning given that term in section 102 of the Controlled Substances Act. The term Indian tribe has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act. For purposes of carrying out this section, section 399O of this Act, and section 102 of the Comprehensive Addiction and Recovery Act of 2016 ( Public Law 114–198 ), there is authorized to be appropriated $496,000,000 for each of fiscal years 2019 through 2023. .
Section 102 of the Comprehensive Addiction and Recovery Act of 2016 ( Public Law 114–198 ) is amended— by amending subsection
(a)to read as follows: The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention and in coordination with the heads of other departments and agencies, shall advance education and awareness regarding the risks related to misuse and abuse of opioids, as appropriate, which may include developing or improving existing programs, conducting activities, and awarding grants that advance the education and awareness of— the public, including patients and consumers— generally; and regarding such risks related to unused opioids and the dispensing options under section 309(f) of the Controlled Substances Act, as applicable; and providers, which may include— providing for continuing education on appropriate prescribing practices; education related to applicable State or local prescriber limit laws, information on the use of non-addictive alternatives for pain management, and the use of overdose reversal drugs, as appropriate; disseminating and improving the use of evidence-based opioid prescribing guidelines across relevant health care settings, as appropriate, and updating guidelines as necessary; implementing strategies, such as best practices, to encourage and facilitate the use of prescriber guidelines, in accordance with State and local law; disseminating information to providers about prescribing options for controlled substances, including such options under section 309(f) of the Controlled Substances Act, as applicable; and disseminating information, as appropriate, on the National Pain Strategy developed by or in consultation with the Assistant Secretary for Health; and other appropriate entities. ; and in subsection (b)— by striking opioid abuse each place such term appears and inserting opioid misuse and abuse ; and in paragraph (2), by striking safe disposal of prescription medications and other and inserting non-addictive treatment options, safe disposal options for prescription medications, and other applicable .
Connectionstraces to 2
Traces to 2 documents
U.S. Code
public-private-law
1 reference not yet in our index
- 42 USC 280b–1
Citation graph
cites case law
Sec. 7161
Preventing overdoses of controlled substances
Cite42 USC 280b–1
Cites 3Cited by 0 across 0 sources